Request a Quote

Month: November 2014

Gut Microbiome & Celiac Disease

Celiac disease research highlights interest in gut microbiome

November 18, 2014

When it comes to gastrointestinal disorders, a growing number of researchers are realizing there is one variable that may deserve more attention: the gut microbiome.

Read More

Medical Team Works on Clinical Trial

Personalized medicine may drive down popularity of randomized controlled trials

For years, researchers conducting experiments to evaluate potential new drugs did so through randomized controlled trials, but personalized medicine is driving alternative development tracks.

Read More

Doctors Look at Laptop Together

Federal report proposes software architecture promoting interoperability

November 16, 2014

During the past few years, the federal government has been pushing for U.S. practitioners and hospitals to adopt electronic health record (EHR) systems. However, the full potential of EHRs cannot be realized until they are adopted more universally and the systems used by various providers are able to easily communicate with each other.

Read More

Female with Melanoma

Scientists find potential drug targets for hard-to-treat melanoma

As gene sequencing technologies became increasingly advanced, scientists are finding new gene fusions and mutations that lead to more targeted therapies. Specifically, scientists have recently found that some “pan-negative” melanomas are responsive to existing medications.

Read More

Proteomics & Geonomics Researcher

Proteomics and genomics research combine to offer more insight into medical conditions

November 13, 2014

Advances in technology are making it possible for scientists to study proteomics more closely and in tandem with genomics, which will greatly improve doctors’ and researchers’ understanding of how diseases develop and how they can be treated.

Read More

Smart Solutions for BioSpecimen Sourcing Infographic

Smarter Solutions for BioSpecimen Sourcing

November 7, 2014

Healthcare providers, scientists and biopharmaceutical companies are all realizing that personalized medicine is the next step in the evolution of patient care. Not only can it treat individuals’ illnesses more effectively, but it can do so while minimizing the likelihood of side effects. These dynamics will improve patient outcomes while curbing healthcare expenses.

Read More

Cardiac System

Biomarker Roundup No. 3

November 5, 2014

Scientists discuss new findings pertaining to atrial fibrillation, epilepsy, leukemia and anti-neutrophil cytoplasmic antibody-associated vasculitis.

Read More

DNA Chalkboard Image

Researchers study ethnic groups to understand genetic component of diseases

November 4, 2014

There are a number of diseases that are uniquely prevalent among distinct population groups and in particular, researchers are studying the genome of the Ashkenazi Jews due to their increased likelihood of developing genetic disorders.

Read More

Blood Sample in Test Tube

IVD market will see significant growth

November 3, 2014

A study indicated that the global IVD market is expanding due in large part to the drive towards personalized medicine and will be worth $88 billion by the year 2020.

Read More